KIF18B and central nervous system cancer: Kaplan-Meier survival analysis, ROC curves for 1, 3, and 5-year survival intervals, and multivariate Cox regression analysis all consistently indicated that KIF18B may function as an independent predictor of unfavorable prognosis in glioma patients.